OBJECTIVE: A three-month prospective trial of a psychosocial intervention--customized adherence enhancement (CAE)--was conducted with 43 medication-nonadherent individuals with bipolar disorder. METHODS: CAE modules were administered as indicated by a screen that identifies reasons for nonadherence. The primary outcome was change in adherence to mood-stabilizing medications as measured by the Tablet Routines Questionnaire and pill counts. Secondary outcomes included change in symptoms, measured by the Hamilton Rating Scale for Depression (HAM-D), Young Mania Rating Scale (YMRS), and Brief Psychiatric Rating Scale (BPRS). RESULTS: Participants completed 76% of sessions. Dropout at three months was 13 (30%). Adherence improved from a baseline mean±SD of 34%±27% of tablets missed in the past month to only 10%±15% (p<.001). BPRS, HAM-D, andYMRS scores all indicated significant improvement at three-month follow-up (p<.05). CONCLUSIONS: Although conclusions must be tempered by the uncontrolled design, CAE appeared to be well accepted and was associated with improvements in adherence, symptoms, and functioning.
OBJECTIVE: A three-month prospective trial of a psychosocial intervention--customized adherence enhancement (CAE)--was conducted with 43 medication-nonadherent individuals with bipolar disorder. METHODS: CAE modules were administered as indicated by a screen that identifies reasons for nonadherence. The primary outcome was change in adherence to mood-stabilizing medications as measured by the Tablet Routines Questionnaire and pill counts. Secondary outcomes included change in symptoms, measured by the Hamilton Rating Scale for Depression (HAM-D), Young Mania Rating Scale (YMRS), and Brief Psychiatric Rating Scale (BPRS). RESULTS:Participants completed 76% of sessions. Dropout at three months was 13 (30%). Adherence improved from a baseline mean±SD of 34%±27% of tablets missed in the past month to only 10%±15% (p<.001). BPRS, HAM-D, andYMRS scores all indicated significant improvement at three-month follow-up (p<.05). CONCLUSIONS: Although conclusions must be tempered by the uncontrolled design, CAE appeared to be well accepted and was associated with improvements in adherence, symptoms, and functioning.
Authors: Adam T Perzynski; Riane K Ramsey; Kari Colón-Zimmermann; Jamie Cage; Elisabeth Welter; Martha Sajatovic Journal: Chronic Illn Date: 2016-10-19
Authors: Jennifer B Levin; Nasim Seifi; Kristin A Cassidy; Curtis Tatsuoka; Johnny Sams; Kouri K Akagi; Martha Sajatovic Journal: J Nerv Ment Dis Date: 2014-11 Impact factor: 2.254
Authors: Thomas Canales; Samuel Rodman; Danette Conklin; Kaylee Sarna; Martha Sajatovic; Jennifer B Levin Journal: Psychopharmacol Bull Date: 2022-06-27
Authors: Martha Sajatovic; Jennifer Levin; Luis F Ramirez; David Y Hahn; Curtis Tatsuoka; Christopher S Bialko; Kristin A Cassidy; Edna Fuentes-Casiano; Tiffany D Williams Journal: J Clin Psychiatry Date: 2013-12 Impact factor: 4.384
Authors: Martha Sajatovic; Curtis Tatsuoka; Kristin A Cassidy; Peter J Klein; Edna Fuentes-Casiano; Jamie Cage; Michelle E Aebi; Luis F Ramirez; Carol Blixen; Adam T Perzynski; Mark S Bauer; Steven A Safren; Jennifer B Levin Journal: J Clin Psychiatry Date: 2018-09-25 Impact factor: 4.384
Authors: Martha Sajatovic; Jennifer B Levin; Johnny Sams; Kristin A Cassidy; Kouri Akagi; Michelle E Aebi; Luis F Ramirez; Steven A Safren; Curtis Tatsuoka Journal: Bipolar Disord Date: 2015-09 Impact factor: 6.744